Our recent interview with Steven Chu, the U.S. secretary of energy, seems to have raised the hackles of hydrogen-fuel-cell supporters. In the interview, Chu said that there are four “miracles” that need to happen before hydrogen fuel cells can be practical. Basically, he says, we need better ways to produce, distribute, and store hydrogen, and we need better, cheaper fuel cells. “If you need four miracles, that’s unlikely: saints only need three miracles,” he said.
Mary Nichols, the chairman of the California Air Resources Board, noticed his remarks and has sent a letter in response, as Green Car Congress reports:
In her letter to Secretary Chu, Nichols attached a summary response from ARB technical staff responding to each of the Four Miracles.
All promising low-carbon non-petroleum transportation options, including hydrogen fuel cell vehicles, battery electric vehicles, and advanced liquid biofuels in combustion engines, face significant technical, resource, and market challenges. Hydrogen and fuel cells show great potential and have met or exceeded nearly all of the technical milestones set out by US DOE. Several major automakers are pursuing early market testing with consumers beginning this year and are expected to ramp up production to nearly 50,000 vehicles in california by 2017. Ultimately the market will decide which technologies are the winners, but given the critical importance to our long term climate and energy security goals, the best approach is to pursue and invest in a portfolio of the most promising options.
See more details of Nichols’s response to Chu here.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.